Compare Alnylam Pharmaceuticals, Inc. (ALNY) vs Ecolab Inc. (ECL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alnylam Pharmaceuticals, Inc. vs Ecolab Inc. — how do they compare? Alnylam Pharmaceuticals, Inc. trades at $288.06 (market cap $39.89B), while Ecolab Inc. trades at $272 (market cap $77.20B). The key difference: Ecolab Inc. is the larger of the two by market cap, and Ecolab Inc. pays a 1.06% dividend while Alnylam Pharmaceuticals, Inc. pays none. Which is the better fit depends on your goals.
| ALNY | ECL | |
|---|---|---|
Market Cap | $39.89B | $77.20B |
Sector | Health | Consumer Cyclical |
52-Week High | $491.22 | $308.35 |
52-Week Low | $278.09 | $245.73 |
Enterprise Value | $38.15B | $85.95B |
Dividend Yield | — | 1.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Read more on ALNY →About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →
